> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Support In-Home Opioid Disposal: AGs
- URL: https://www.fdaweb.com/support-in-home-opioid-disposal-ags/
- Published: 2023-06-22T12:00:00.000Z
- Updated: 2026-09-14T18:40:36.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5154745

The attorneys general of 13 states are urging FDA to include the use of in-home opioid disposal products in its approach to opioid disposal. Responding to an agency request for information on in-home opioid disposal systems, the attorneys general of South Carolina, Idaho, Alabama, Indiana, Alaska, Iowa, Arkansas, Kentucky, Louisiana, North Dakota, Mississippi, Utah, and Montana [write](https://www.scag.gov/media/zjifn40w/fda-comment-letter-in-home-opioid-disposal-final-signed.pdf?ref=fdaweb.com) that the approach they suggest “recognizes the seriousness of the problem we collectively face and acknowledges that increasing proper drug disposal requires more than a one-size-fits-all solution.”

The letter says there is strong evidence supporting the efficacy of non-mail-back in-home single-use drug disposal products, with studies reportedly showing that when the products are paired with education, proper drug disposal can be increased to at least 92%. The attorneys general also say studies show that patients prefer in-home single-use products to mail-back programs.

While a mail-back option could be part of an all-encompassing approach, the letter says, the attorneys general raise concerns about mail-back programs. They say a mail-back program could complicate existing enforcement efforts since drug traffickers frequently exploit the U.S. Postal Service and other carriers to traffic drugs. They also voice a concern about the insecurity of mailboxes and the inconvenience for many rural Americans.

“While we applaud FDA for its work towards helping the numerous Americans with leftover prescription drugs at home dispose of those drugs properly,” the letter concludes, “we believe an approach providing flexibility to choose in-home single-use products would achieve better public health and public policy results. We urge FDA to work with states in reviewing innovative programs across the country designed to increase proper drug disposal while mitigating the risk of nonmedical use or overdose.”